Contrast-enhanced US and MRI for assessing the response of breast cancer to neoadjuvant chemotherapy()

Por Corcioni, B., Santilli, L., Quercia, S., Zamagni, C., Santini, D., Taffurelli, M., Mignani, S.
Publicado em 2008

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

Por Bengala, C, Zamagni, C, Pedrazzoli, P, Matteucci, P, Ballestrero, A, Da Prada, G, Martino, M, Rosti, G, Danova, M, Bregni, M, Jovic, G, Guarneri, V, Maur, M, Conte, P F
Publicado em 2006

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?

Por Cazzaniga ME, Biganzoli L, Cortesi L, De Placido S, Donadio M, Fabi A, Ferro A, Generali D, Lorusso V, Milani A, Montagna E, Munzone E, Orlando L, Pizzuti L, Simoncini E, Zamagni C, Pappagallo GL
Publicado em 2019-04-01